online resources

• American Clinical Laboratory Association Results for Life
  Lab Testing: Making a Difference in Patient's Lives
  Lab tests detect strep throat, diabetes, heart disease, allergies, cervical cancer, lead poisoning, HIV, kidney ailments, and West Nile Virus - and that's just a start. But the most important job lab tests do is provide information - the single most important thing that physicians and patients need to bring disease under control. "Results for Life" tells the story of why that matters in patients' lives.
• Personalized Medicine e-Symposium 2006
  Hosted by the International Society of Pharmacogenomics
  View Archive (free registration required)
• Critical Path Opportunities List
  HHS and FDA released an initial list of priority research projects that could advance innovation in medical products. The announcement of the Critical Path Opportunities List signals the next major step in FDA's Critical Path Initiative, aimed at modernizing medical product development, so new medical discoveries are brought to patients faster and at a lower cost. The Opportunities List outlines an initial 76 projects to bridge the gap between the quick pace of new biomedical discoveries and the slower pace at which those discoveries are currently developed into therapies.
  
• FDA Guidance on Pharmacogenomics Tests and Genetic Tests for Heritable Markers
  View HTML or View PDF
  
• The final report of the Health Information Technology (HIT) Leadership Panel
  The HIT Leadership Panel was convened to examine the importance of investing in HIT, particularly regarding the respective major roles of government and the private sector in its widespread implementation. HIT Leadership Panel members were drawn from executives in widely recognized companies that purchase substantial levels of health care for their employees.
  
• CDC: Evaluation of Genomic Applications in Practice and Prevention (EGAPP)
  Evaluation of Genomic Applications in Practice and Prevention (EGAPP) is a three-year model project by the Centers for Disease Control that is now underway. The goal is to establish and test a systematic, evidence-based process for evaluating genetic tests or other applications of genomic technology that are in transition from research to practice, and to effectively disseminate that information to health care providers, consumers, and other important stakeholders.
  
• Genomics at FDA
  Information on activities at the FDA related to incorporating genomics into the regulatory process.
  
• HHS: Secretary's Advisory Committee on Genetics, Health and Society
  The Department of Health and Human Services (HHS) established SACGHS to serve as a public forum for deliberations on the broad range of human health and societal issues raised by the development and use of genetic technologies and, as warranted, to provide advice on these issues.
  
• NIH NIGMS Pharmacogenetics Research Network and Knowledge Base